BIOLIFE SOLUTIONS INC (BLFS) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for BIOLIFE SOLUTIONS INC (BLFS): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 48/100 — a percentile rank of BIOLIFE SOLUTIONS INC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $1.8B |
| P / E | 31.0× |
| P / S | 17.5× |
| EV / EBITDA | 277.0× |
| Gross margin | 63.9% |
| Operating margin | 2.9% |
| Net margin | 56.4% |
| Return on equity | 13.8% |
| ROIC | 4.7% |
| Revenue growth | 25.4% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Is BIOLIFE SOLUTIONS INC overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from BIOLIFE SOLUTIONS INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact